These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 785150)

  • 1. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
    Fidetzis K; Brosteano R; Keller P
    Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P; Caron JC
    Lille Med; 1971 Apr; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G; Elefante R; Granata F; Graziussi G
    Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O
    Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T; Passeri F; Locatelli F
    Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
    Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled multicenter clinical studies on the effect of (-)eburnamonine versus placebo in patients with chronic senile cerebral insufficiency of medium significance].
    Aveni-Casucci MA; Canal N; Corsico R; Passeri M; Porro A; Ventura A
    G Clin Med; 1983; 64(9-10):372-94. PubMed ID: 6363189
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 20. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.